- 1 child dies from malaria every 60 seconds.
- 219 million cases of malaria occur worldwide every year.
- 104 malaria endemic countries.
Increase access to malaria diagnosis
An early malaria diagnosis allows the better treatment of the disease but also reduces the emergence of drug resistance. Since its publication on March 2010, the WHO has recommended to conduct a parasitological confirmation with a rapid test or a microscopic examination before any curative treatment*.
* World Health Organization; Guidelines for the treatment of Malaria - second edition; March 2010
Our commitment to the fight against Malaria
In January 2013, bioMérieux launched VIKIA® Malaria Ag Pf/Pan, the first rapid diagnostic test (RDT) in the tropical and neglected disease panel currently being developed through bioMérieux’s collaboration with IMAccess.
IMAccess is a subsidiary of the Institut Mérieux. The company adopted a “not-for-profit” business model dedicated to fighting infectious diseases in developing countries through the development of rapid diagnostic tests. IMAccess aims to increase access to the greatest number of people to reliable and accessible diagnostic tools.